David Schaffer

Scientific Advisor at Tessera Therapeutics

David Schaffer is a Professor of Chemical and Biomolecular Engineering, Bioengineering, Molecular and Cell Biology, and the Helen Wills Neuroscience Institute at U.C. Berkeley.

He has served as the Director of the Berkeley Stem Cell Center since 2011. In addition, he is co-founder and since 2013 has served as Chief Scientific Advisor and a member of the board of directors of 4D Molecular Therapeutics. He has also co-founded five other companies.

He has served on the board of directors of the NASDAQ-listed company uniQure NV since January, 2014. Dr. Schaffer received a B.S. in Chemical Engineering from Stanford University in 1993 and his Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology in 1998.